The Conference will cover: Controls acting over genome duplication, Replication Stress, signalling at replication forks, DNA repair, DNA damage response and tolerance pathways and their cross-talk with cellular processes and immune responses in cancer, highlighting the role of key players maintaining genome integrity and driving tumour evolution. Synthetic lethality approaches to exploit this knowledge towards novel targeted therapies will be discussed.